![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Correlation of Early Biochemical and Virologic
Responses During Oral Antiviral Therapy for Chronic Hepatitis B
|
|
|
Reported by Jules Levin
APASL 2017 Feb 15-19 Shanghai, China
Sang Hoon Ahn1, Maurizia R. Brunetto2, Ting-Tsung Chang3, Seng-Gee Lim4, Adrian Streinu-Cercel5, John F. Flaherty6, Kyungpil Kim6, Anuj Gaggar6, Mani Subramanian6, Wendy Cheng7, Magdy Elkhashab8, Namiki Izumi9
1Yonsei University College of Medicine, Seoul, Korea; 2Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy; 3National Cheng Kung University Hospital, Tainan, Taiwan; 4National University Hospital, Singapore; 5Institutul National de Boli Infectioase "Prof. Dr. Matei Bals," Bucharest, Romania; 6Gilead Sciences, Inc., Foster City, CA, USA; 7Royal Perth Hospital, Perth, Western Australia, Australia; 8Toronto Liver Centre, Toronto, Ontario, Canada; 9Japanese Red Cross Musashino Hospital, Tokyo, Japan
![CROI1](../images/031617/031617-5/CROI1.gif)
![CROI2](../images/031617/031617-5/CROI2.gif)
![CROI3](../images/031617/031617-5/CROI3.gif)
![CROI4](../images/031617/031617-5/CROI4.gif)
![CROI5](../images/031617/031617-5/CROI5.gif)
![CROI6](../images/031617/031617-5/CROI6.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|